Go to homepage
€0.00*
Categories
Decode the translatome. Transform medicine.

Technologies for ribosome, coding & non-coding RNA, tRNA and proteome discovery

Simple solutions accessible to all Discover more
double-arrow
Decode the translatome. Transform medicine.

Technologies for ribosome, coding & non-coding RNA, tRNA and proteome discovery






Simple solutions accessible to all Discover more
double-arrow

Our integrated solutions

Products Services

Ribosome Profiling

Products Services

tRNA Sequencing

Services

Translatome Biomarker Discovery

Products Services

In vitro Translation

Products

Proteomics

Services

Data Analysis

About Immagina

About Immagina

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

About Immagina

About Immagina

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

What our costumers say

“Using the ALL-IN-ONE RiboLace Gel-Free Kit, we are able to complete the entire Ribo-seq workflow within three days without the need for ultracentrifugation. In addition, both the experimental protocol and the data analysis pipeline are straightforward and easy to follow. The results have been consistently excellent and highly reproducible. Highly recommended.”
Dr. Yang Yi
Assistant Professor, Northwestern University
Read paper
“The nano-tRNAseq kit does exactly what it promisses. Just followed the exact protocol and was able to get more than enough material for the pooling and sequencing. Highly recommend this straightforward kit to prepare tRNAs for nanopore sequencing”
Dr. Ana Raquel Soares
Assistant Researcher, University of Aveiro
Read paper
div class="custom-testimonial theme-green">
“Their translatome approach enabled biomarker discovery...”
Dr. Maria Rossi
University of Milan

Recent news & events

Blog

13 April 2026

Immagina Blog Image_1

What is Translatomics? The Missing Layer in Gene Expression

Why do RNA-seq data show upregulation of a key gene while protein levels do not match? This blog explains the disconnect between transcriptomics and proteomics, and shows why translatomics helps reveal which mRNAs are actually being translated.

Webinar & podcast

10 February 2026

Doors podcast thumbnail-01

DOORs: the next generation RNA diagnostic platform

In this podcast episode, we dive into our DOORs platform (Detection Of phOspho RNAs). Learn more about how we leverage it to detect 3'P RNA fragments in the bloodstream, and how these are arising as promising, non-invasive biomarkers for cancer.

This website uses cookies to ensure the best experience possible. More information...